Clinical Trial Update: Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating abatacept (Orencia) effects on apoptosis of T cells, B cells, and antigen-presenting cells in rheumatoid arthritis; the study has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Apoptotic DNA Damage, Rheumatoid Arthritis | Phase 4 | Status: WITHDRAWN